TOFACITINIB CITRATE

Product NDC
68254-5011
11-digit product format
682545011
Labeler code
68254
Product ID
68254-5011_ad6e5467-da25-405d-a725-c95489d79aab
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
TOFACITINIB CITRATE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
CONCORD BIOTECH LIMITED
Application
ANDA218821
Marketing category
ANDA
Marketing start
2026-10-01
Substance
TOFACITINIB CITRATE
Active strength
8.08 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218821-001TOFACITINIB CITRATETOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-09
A218821-002TOFACITINIB CITRATETOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-09

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A218821-001AB
A218821-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A218821-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-09d4dbc9d85df4…
2026-11-14 07:37:172026-10A218821-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-09d4dbc9d85df4…
2026-10-15 13:18:302026-09A218821-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-09c2088c7a36db…
2026-10-15 13:18:302026-09A218821-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-09c2088c7a36db…
2026-09-14 22:38:342026-08A218821-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-0984e616aacf4f…
2026-09-14 22:38:342026-08A218821-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-0984e616aacf4f…
2026-08-18 06:07:402026-07A218821-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-09caaa826d4ba7…
2026-08-18 06:07:402026-07A218821-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-09caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218821-001TOFACITINIB CITRATEEQ 5MG BASETABLET / ORALAB2026-06-09a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218821-002TOFACITINIB CITRATEEQ 10MG BASETABLET / ORALAB2026-06-09a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A218821-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A218821-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A218821-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A218821-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A218821-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A218821-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A218821-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A218821-002AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218821-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218821-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
TOFACITINIB CITRATE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TOFACITINIB CITRATE8.08 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O1FF4DIV0DInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1357541Internal RxNorm lookup
2048566Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6c33e5b4-4843-4a80-a4f8-435bfceddc2aAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOFACITINIB CITRATETOFACITINIB CITRATEStellon Biotech Inc.89eb2ffc-02d9-4b46-b480-e9b10af330272026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218821
application number: ANDA218821
TOFACITINIB CITRATETOFACITINIB CITRATECONCORD BIOTECH LIMITED6c33e5b4-4843-4a80-a4f8-435bfceddc2a2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218821
application number: ANDA218821
ndc (product): 68254-5011

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68254-5011-16825450110128 TABLET, FILM COATED in 1 BOTTLE (68254-5011-1) 2026-10-01NoNoCurrent
68254-5011-26825450110260 TABLET, FILM COATED in 1 BOTTLE (68254-5011-2) 2026-10-01NoNoCurrent